QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
NASDAQ:AFYA

Afya (AFYA) Stock Price, News & Analysis

$20.50
+0.81 (+4.11%)
(As of 02/22/2024 ET)
Today's Range
$19.79
$20.58
50-Day Range
$19.62
$22.37
52-Week Range
$9.66
$22.48
Volume
104,957 shs
Average Volume
125,172 shs
Market Capitalization
$1.92 billion
P/E Ratio
26.28
Dividend Yield
N/A
Price Target
$23.00

Afya MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
12.2% Upside
$23.00 Price Target
Short Interest
Healthy
2.67% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.05mentions of Afya in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
36.28%
From $1.13 to $1.54 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.95 out of 5 stars

Consumer Discretionary Sector

141st out of 260 stocks

Educational Services Industry

13th out of 22 stocks


AFYA stock logo

About Afya Stock (NASDAQ:AFYA)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

AFYA Stock Price History

AFYA Stock News Headlines

Bill Gates is raving about WHAT?!
The legendary Microsoft founder says that this tech "will be as revolutionary as the personal computer." It could create a new generation of millionaire investors by the end of the decade. 
AI Stock Caught Trading Under Secret Name
We have uncovered perhaps the most unusual AI stock we've ever seen.It's expected to see massive revenue this year - $215 billion.  The company holds over 29,000 patents in the U.S. It pays an enormous dividend.
Doctors Issue Demands After Interns Strike
Afya (AFYA) Rises As Market Takes a Dip: Key Facts
Mvinyo hauna manufaa kwa Afya yako
See More Headlines
Receive AFYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Afya and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/26/2021
Today
2/22/2024
Next Earnings (Estimated)
3/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Educational services
Sub-Industry
N/A
Current Symbol
NASDAQ:AFYA
Fax
N/A
Employees
8,708
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$23.00
High Stock Price Target
$23.00
Low Stock Price Target
$23.00
Potential Upside/Downside
+12.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$72.36 million
Pretax Margin
15.25%

Debt

Sales & Book Value

Annual Sales
$451.09 million
Cash Flow
$1.47 per share
Book Value
$6.72 per share

Miscellaneous

Free Float
92,973,000
Market Cap
$1.92 billion
Optionable
Optionable
Beta
0.98

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report














AFYA Stock Analysis - Frequently Asked Questions

Should I buy or sell Afya stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Afya in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" AFYA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AFYA, but not buy additional shares or sell existing shares.
View AFYA analyst ratings
or view top-rated stocks.

What is Afya's stock price target for 2024?

3 brokers have issued twelve-month target prices for Afya's stock. Their AFYA share price targets range from $23.00 to $23.00. On average, they predict the company's stock price to reach $23.00 in the next twelve months. This suggests a possible upside of 12.2% from the stock's current price.
View analysts price targets for AFYA
or view top-rated stocks among Wall Street analysts.

How have AFYA shares performed in 2024?

Afya's stock was trading at $21.93 at the start of the year. Since then, AFYA shares have decreased by 6.5% and is now trading at $20.50.
View the best growth stocks for 2024 here
.

When is Afya's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 27th 2024.
View our AFYA earnings forecast
.

How were Afya's earnings last quarter?

Afya Limited (NASDAQ:AFYA) posted its quarterly earnings data on Wednesday, May, 26th. The company reported $1.16 EPS for the quarter, missing analysts' consensus estimates of $1.56 by $0.40. The company earned $72.15 million during the quarter, compared to analysts' expectations of $72.96 million. Afya had a net margin of 13.15% and a trailing twelve-month return on equity of 15.08%.
Read the conference call transcript
.

What ETFs hold Afya's stock?

ETFs with the largest weight of Afya (NASDAQ:AFYA) stock in their portfolio include None (BKES).VanEck Brazil Small-Cap ETF (BRF).

What other stocks do shareholders of Afya own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Afya investors own include Pfizer (PFE), Cisco Systems (CSCO), Procter & Gamble (PG), RTX (RTX), Abbott Laboratories (ABT), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA) and CSX (CSX).

When did Afya IPO?

(AFYA) raised $233 million in an initial public offering (IPO) on Friday, July 19th 2019. The company issued 13,700,000 shares at $16.00-$18.00 per share. BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itaú BBA, Morgan Stanley, BTG and Pactual XP Investments served as the underwriters for the IPO.

Who are Afya's major shareholders?

Afya's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Perpetual Ltd (0.86%), Massachusetts Financial Services Co. MA (0.35%), Doma Perpetual Capital Management LLC (0.31%), FIL Ltd (0.31%), Renaissance Group LLC (0.16%) and DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main (0.15%).

How do I buy shares of Afya?

Shares of AFYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AFYA) was last updated on 2/22/2024 by MarketBeat.com Staff